Home > Healthcare > Pharmaceuticals > Finished Drug Form > Oral Expectorant Market
Oral Expectorant Market Size
- Report ID: GMI8788
- Published Date: Apr 2024
- Report Format: PDF
Oral Expectorant Market Size
Oral Expectorant Market was valued at USD 4.2 billion in 2023 and is expected to reach USD 5.7 billion by 2032 growing at a CAGR of 3.4% over the analysis period, due to the increasing prevalence of respiratory diseases worldwide, which necessitated the development of novel and effective treatment options.
According to the National Library of Medicine estimation in 2023, acute bronchitis is one of the top 10 most prevalent outpatient illnesses in the U.S., impacting around 5% of adults each year. Thus, the escalating global respiratory disease burden is expected to surge the demand for oral expectorant, thereby propelling the market expansion.
An oral expectorant is a type of medication commonly used to help loosen mucus and phlegm in the respiratory tract, making it easier to cough up and expel from the body. These medications are often used to alleviate symptoms associated with respiratory conditions such as coughs, bronchitis, and chest congestion.
| Report Attribute | Details |
|---|---|
| Base Year: | 2023 |
| Oral Expectorant Market Size in 2023: | USD 4.2 billion |
| Forecast Period: | 2024 to 2032 |
| Forecast Period 2024 to 2032 CAGR: | 3.4% |
| 2032 Value Projection: | USD 5.7 billion |
| Historical Data for: | 2021 - 2023 |
| No. of Pages: | 180 |
| Tables, Charts & Figures: | 271 |
| Segments covered: | Drug Type, Dosage Form, Medication, Distribution Channel, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Oral Expectorant Market Scope
